Cytori Therapeutics buy marge
Start price
13.04.17
/
50%
?0.97
Target price
03.01.18
€1.80
Performance (%)
-73.76%
End price
03.01.18
€0.25
Summary
This prediction ended on 03.01.18 with a price of €0.25. The BUY prediction by marge for Cytori Therapeutics performed very badly with a performance of -73.76%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cytori Therapeutics | - | - | - | - |
| iShares Core DAX® | -5.585% | -6.284% | 8.869% | 8.070% |
| iShares Nasdaq 100 | -7.241% | -13.117% | 18.200% | 28.955% |
| iShares Nikkei 225® | -8.933% | -10.904% | 2.614% | -1.478% |
| iShares S&P 500 | -6.148% | -7.562% | 17.896% | 31.811% |
Comments by marge for this prediction
In the thread Cytori Therapeutics diskutieren
marge stimmt der Buy-Einschätzung von zeckenjoe zu
Cytori Therapeutics (CYTX) announces that the FDA has approved an Investigational Device Exemption
(IDE) for a pilot clinical trial to evaluate Cytori Cell Therapy in patients with thermal burn injury,
with shares ahead 23% premarket, and announced 10.04 that it intends to offer and sell shares of its common stock in an underwritten public offering, with shares down -36%.
Trading hoch 3
(Vom Mitglied beendet)